ABSTRACT
Lung cancer is the leading cause of cancer death worldwide accounting for over 1 million victims annually.1 Despite all efforts in conventional treatment of lung cancer by surgery, radiotherapy and chemotherapy, the survival of lung cancer has seen only minor improvements over the last 25 years. The main reason for this lack of progress is related to the fact that lung cancer is a conglomerate of diseases that elicit symptoms in a relatively late stage. Thus in most cases the diagnosis is being made when the disease has significantly advanced and is beyond the stage of cure.
